Controlled substances: gamma-butyrolactone.
Vote required
Majority
Fiscal committee
No
Appropriation
No
Current location
Enrolled
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed Assembly
- To Governor
- Became Law
Overview
This bill modifies California law to exempt certain chemical mixtures containing gamma-butyrolactone (GBL) from existing reporting and permitting requirements. Specifically, it addresses a discrepancy between California’s regulations and federal guidelines, which allow for exemptions for GBL mixtures with a concentration of 70% or less. The bill aims to reduce compliance burdens on semiconductor manufacturers in California who utilize these mixtures.
Key provisions
- Exempts chemical mixtures containing GBL with a concentration of 70% or less from state reporting requirements.
- Applies this exemption to mixtures obtained from sources within or outside California.
- Specifically addresses a misalignment between California law (Section 11100) and federal regulations (DEA’s 2010 rulemaking).
- Clarifies definitions related to ‘chemical mixtures containing gamma-butyrolactone’ and ‘inert carrier’.
- Relates to Section 11112 of the Health and Safety Code.
Who is affected
- Semiconductor manufacturers
- Chemical distributors
- California Department of Justice
- Businesses utilizing GBL in chemical mixtures
Notable changes
- Aligns California law with federal exemptions for GBL mixtures.
- Reduces compliance requirements for semiconductor manufacturers.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours